Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer and AstraZeneca are combined in a two-shot schedule.
Flora Bradley-Watson reports.
Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer and AstraZeneca are combined in a two-shot schedule.
Flora Bradley-Watson reports.
More than 20 million people across the United Kingdom have now received a COVID-19 shot, Britain's health minister, Matt Hancock,..
Which would you prefer? In Serbia, people can select any of four jabs: the one developed by Pfizer-BioNTech, China’s Sinopharm,..